December 2022
190 articles-
Dec 29 · 22:48Biotechnology Daily
FDA extends deadline to decide on Gamida Cell's stem cell transplant therapy by three months
-
Dec 29 · 22:46Biotechnology Daily
In ObsEva's latest attempt to stay afloat, the Swiss biotech offloads one of 2 remaining assets
-
Dec 29 · 22:44Biotechnology Daily
Clutching post hoc analyses, Khondrion forges on despite phase 2 mitochondrial disease fail
-
Dec 29 · 22:42Biotechnology Daily
Zika antibody prevents infection and suppresses the virus
-
Dec 29 · 22:39Bio Business News
Teleflex plans layoffs amid restructuring plan costing up to $40M
-
Dec 29 · 22:34Bio Business News
Pfizer's $1B protein degradation bet yields 3% response rate in Arvinas' midphase breast cancer trial
-
Dec 29 · 22:32Bio Business News
Novo Nordisk invests $749M to boost API manufacturing for clinical trials
-
Dec 29 · 22:28Bio Business News
FogPharma hauls in $178M series D, the company's 2nd consecutive 9-digit financing round
-
Dec 28 · 22:43Biotechnology Daily
H2o Therapeutics makes a splash with FDA nod for Parkinson's-monitoring Apple Watch app
-
Dec 28 · 22:40Biotechnology Daily
Merck KGaA turns to deals, 'leaner' organization to expedite R&D. Will layoffs follow?
-
Dec 28 · 22:37Biotechnology Daily
As STDs proliferate, companies rush to market at-home test kits. But are they reliable?
-
Dec 28 · 22:34Biotechnology Daily
Siemens Healthineers inks MRI deal to harness HeartVista's cardiac imaging AI
-
Dec 28 · 22:29Bio Business News
Bristol Myers CEO already reassessing portfolio in wake of US pricing law: report
-
Dec 28 · 22:24Bio Business News
Philips pauses repair-and-replace program for some recalled ventilators after 2 new safety issues arise
-
Dec 28 · 22:18Bio Business News
AbbVie's Roche-rivaling blood cancer bispecific gets FDA priority review, triggering Genmab payday
-
Dec 28 · 22:15Bio Business News
Equillium cancels Metacrine buy, citing 'strong financial position' after Ono deal
-
Dec 27 · 21:47Biotechnology Daily
Replay at it again, this time targeting rare skin disease with 2nd company launch
-
Dec 27 · 21:46Biotechnology Daily
FDA grants 3rd monkeypox test authorization to Roche as cases decline
-
Dec 27 · 21:45Biotechnology Daily
After FDA setback, MEI, Kyowa confirm phase 2 efficacy with Japanese blood cancer data drop
-
Dec 27 · 21:44Biotechnology Daily
Inovio drops Lassa, MERS vaccines as clinical data fall short, gutting infectious disease pipeline
-
Dec 27 · 21:43Bio Business News
FDA wants confirmatory trials to be underway before granting accelerated cancer nods, Pazdur says
-
Dec 27 · 21:42Bio Business News
Elizabeth Holmes sentenced to 11-plus years in prison for defrauding Theranos investors
-
Dec 27 · 21:41Bio Business News
Sema4 lays off another 448 employees amid exit from reproductive health testing
-
Dec 27 · 21:40Bio Business News
Lysogene's lead gene therapy flunks phase 2/3 trial almost a year after Sarepta walked out